You just read:

aTyr Pharma Receives FDA Fast Track Designation for Resolaris™ to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)

News provided by

aTyr Pharma, Inc.

Oct 24, 2016, 08:00 ET